rs149469954

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004525.3(LRP2):​c.5209C>T​(p.Leu1737Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00152 in 1,613,992 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 3 hom. )

Consequence

LRP2
NM_004525.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.786

Publications

6 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062796474).
BP6
Variant 2-169231732-G-A is Benign according to our data. Variant chr2-169231732-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211399.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00125 (191/152242) while in subpopulation NFE AF = 0.00171 (116/68024). AF 95% confidence interval is 0.00145. There are 0 homozygotes in GnomAd4. There are 84 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.5209C>T p.Leu1737Phe missense_variant Exon 31 of 79 ENST00000649046.1 NP_004516.2 P98164Q7Z5C0Q7Z5C1
LRP2XM_011511183.4 linkc.5209C>T p.Leu1737Phe missense_variant Exon 31 of 78 XP_011509485.1
LRP2XM_047444340.1 linkc.4285C>T p.Leu1429Phe missense_variant Exon 31 of 79 XP_047300296.1
LRP2XM_011511184.3 linkc.2920C>T p.Leu974Phe missense_variant Exon 16 of 64 XP_011509486.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.5209C>T p.Leu1737Phe missense_variant Exon 31 of 79 NM_004525.3 ENSP00000496870.1 P98164

Frequencies

GnomAD3 genomes
AF:
0.00126
AC:
191
AN:
152124
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00125
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00171
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00120
AC:
300
AN:
250994
AF XY:
0.00120
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.000636
Gnomad ASJ exome
AF:
0.00993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.00134
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00154
AC:
2256
AN:
1461750
Hom.:
3
Cov.:
31
AF XY:
0.00149
AC XY:
1083
AN XY:
727200
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33468
American (AMR)
AF:
0.000738
AC:
33
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00907
AC:
237
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86250
European-Finnish (FIN)
AF:
0.000655
AC:
35
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
0.00162
AC:
1800
AN:
1111934
Other (OTH)
AF:
0.00232
AC:
140
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
127
254
380
507
634
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00125
AC:
191
AN:
152242
Hom.:
0
Cov.:
32
AF XY:
0.00113
AC XY:
84
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41548
American (AMR)
AF:
0.00124
AC:
19
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00171
AC:
116
AN:
68024
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00155
Hom.:
0
Bravo
AF:
0.00122
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00279
AC:
24
ExAC
AF:
0.00105
AC:
127
EpiCase
AF:
0.00147
EpiControl
AF:
0.00113

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25533962) -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LRP2: BS2 -

Donnai-Barrow syndrome Benign:2
May 22, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Sep 12, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LRP2-related disorder Benign:1
Dec 12, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
5.9
DANN
Benign
0.96
DEOGEN2
Benign
0.080
T;T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.76
.;T
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.0063
T;T
MetaSVM
Uncertain
-0.15
T
MutationAssessor
Benign
1.7
L;L
PhyloP100
0.79
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.010
.;N
REVEL
Benign
0.20
Sift
Benign
0.052
.;T
Sift4G
Uncertain
0.021
.;D
Polyphen
0.40
B;B
Vest4
0.036
MVP
0.19
MPC
0.30
ClinPred
0.016
T
GERP RS
-0.28
Varity_R
0.049
gMVP
0.26
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149469954; hg19: chr2-170088242; COSMIC: COSV55569619; API